Pearls in a shell

Numab Therapeutics

Industry
Immuno-Oncology and Inflammation
Company status
Private

Numab applies its proprietary antibody discovery and engineering technology to generate highly potent and stable antibody Fv fragments, which serve as building blocks to create mono- or multispecific antibody fragment-based therapeutics with tailored pharmacokinetic properties.
The company has created a broad proprietary pipeline of compounds in immune-oncology and the field of inflammation and has entered into several partnerships with pharmaceutical companies.

Back